FDA approves oral Utebzi antibiotic for complicated urinary tract infections (opens in new tab)
The U.S. Food and Drug Administration has approved GSK's Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections (cUTIs).
Read the original article